Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avid Technology, Inc. stock logo
AVID
Avid Technology
$27.04
$26.99
$19.78
$33.41
$1.19B1.13483,812 shsN/A
Docebo Inc. stock logo
DCBO
Docebo
$44.00
-1.2%
$49.04
$29.40
$56.41
$1.34B1.6490,651 shs38,967 shs
3D Systems Co. stock logo
DDD
3D Systems
$3.44
-1.2%
$4.33
$3.32
$11.09
$458.33M1.751.64 million shs983,809 shs
Enfusion, Inc. stock logo
ENFN
Enfusion
$9.42
+1.3%
$9.14
$7.37
$11.56
$1.21B1385,056 shs325,889 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avid Technology, Inc. stock logo
AVID
Avid Technology
0.00%0.00%0.00%0.00%-8.28%
Docebo Inc. stock logo
DCBO
Docebo
-1.07%+0.93%-11.64%-1.48%+24.55%
3D Systems Co. stock logo
DDD
3D Systems
-0.71%+2.51%-19.93%-31.59%-60.51%
Enfusion, Inc. stock logo
ENFN
Enfusion
-0.64%-0.11%+1.42%+8.65%+11.52%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avid Technology, Inc. stock logo
AVID
Avid Technology
1.4123 of 5 stars
1.00.00.04.01.11.73.1
Docebo Inc. stock logo
DCBO
Docebo
3.7336 of 5 stars
4.53.00.00.02.60.81.9
3D Systems Co. stock logo
DDD
3D Systems
2.6423 of 5 stars
3.01.00.02.21.31.70.6
Enfusion, Inc. stock logo
ENFN
Enfusion
1.3667 of 5 stars
0.83.00.00.00.04.23.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avid Technology, Inc. stock logo
AVID
Avid Technology
2.00
Hold$27.03-0.06% Downside
Docebo Inc. stock logo
DCBO
Docebo
2.91
Moderate Buy$61.4039.55% Upside
3D Systems Co. stock logo
DDD
3D Systems
2.00
Hold$7.25111.06% Upside
Enfusion, Inc. stock logo
ENFN
Enfusion
1.67
Reduce$9.33-0.92% Downside

Current Analyst Ratings

Latest AVID, DDD, DCBO, and ENFN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/19/2024
Docebo Inc. stock logo
DCBO
Docebo
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$67.00 ➝ $65.00
3/13/2024
Enfusion, Inc. stock logo
ENFN
Enfusion
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$8.00 ➝ $9.00
2/28/2024
Enfusion, Inc. stock logo
ENFN
Enfusion
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Sell$9.00 ➝ $8.00
2/26/2024
Docebo Inc. stock logo
DCBO
Docebo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$50.00 ➝ $65.00
2/26/2024
Docebo Inc. stock logo
DCBO
Docebo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$60.00 ➝ $70.00
2/26/2024
Docebo Inc. stock logo
DCBO
Docebo
Eight Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy$75.00 ➝ $65.00
2/26/2024
Docebo Inc. stock logo
DCBO
Docebo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$44.00 ➝ $55.00
2/26/2024
Docebo Inc. stock logo
DCBO
Docebo
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$60.00 ➝ $65.00
2/26/2024
Docebo Inc. stock logo
DCBO
Docebo
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$63.00 ➝ $67.00
2/13/2024
3D Systems Co. stock logo
DDD
3D Systems
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$8.50
1/30/2024
Enfusion, Inc. stock logo
ENFN
Enfusion
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Underweight$11.00 ➝ $9.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avid Technology, Inc. stock logo
AVID
Avid Technology
$417.41M2.85$1.26 per share21.42($2.72) per share-9.94
Docebo Inc. stock logo
DCBO
Docebo
$180.84M7.39$0.59 per share74.83$1.67 per share26.35
3D Systems Co. stock logo
DDD
3D Systems
$488.07M0.94N/AN/A$3.14 per share1.09
Enfusion, Inc. stock logo
ENFN
Enfusion
$174.54M6.91$0.15 per share64.87$0.61 per share15.44

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avid Technology, Inc. stock logo
AVID
Avid Technology
$55.24M$0.7337.0417.79N/A7.59%-27.20%12.39%N/A
Docebo Inc. stock logo
DCBO
Docebo
$2.84M$0.09488.9433.33N/A1.57%12.45%6.57%5/9/2024 (Confirmed)
3D Systems Co. stock logo
DDD
3D Systems
-$370.43M-$2.84N/AN/AN/A-75.90%-9.34%-4.56%5/13/2024 (Estimated)
Enfusion, Inc. stock logo
ENFN
Enfusion
$6.03M$0.08117.7655.412.733.45%10.30%7.78%5/9/2024 (Confirmed)

Latest AVID, DDD, DCBO, and ENFN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Docebo Inc. stock logo
DCBO
Docebo
$0.16N/A-$0.16N/AN/AN/A
5/9/2024N/A
Enfusion, Inc. stock logo
ENFN
Enfusion
$0.0370N/A-$0.0370N/AN/AN/A  
3/12/2024Q4 2023
Enfusion, Inc. stock logo
ENFN
Enfusion
$0.03$0.01-$0.02$0.01$45.56 million$46.49 million
2/27/2024Q4 2023
3D Systems Co. stock logo
DDD
3D Systems
-$0.07-$0.17-$0.10$1.96$124.33 million$114.85 million
2/23/2024Q4 2023
Docebo Inc. stock logo
DCBO
Docebo
$0.09$0.21+$0.12$0.32$48.46 million$49.28 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avid Technology, Inc. stock logo
AVID
Avid Technology
N/AN/AN/AN/AN/A
Docebo Inc. stock logo
DCBO
Docebo
N/AN/AN/AN/AN/A
3D Systems Co. stock logo
DDD
3D Systems
N/AN/AN/AN/AN/A
Enfusion, Inc. stock logo
ENFN
Enfusion
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avid Technology, Inc. stock logo
AVID
Avid Technology
N/A
1.06
0.89
Docebo Inc. stock logo
DCBO
Docebo
0.01
1.26
1.26
3D Systems Co. stock logo
DDD
3D Systems
0.76
4.30
3.24
Enfusion, Inc. stock logo
ENFN
Enfusion
N/A
3.44
3.44

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Avid Technology, Inc. stock logo
AVID
Avid Technology
84.96%
Docebo Inc. stock logo
DCBO
Docebo
53.17%
3D Systems Co. stock logo
DDD
3D Systems
64.49%
Enfusion, Inc. stock logo
ENFN
Enfusion
81.05%

Insider Ownership

CompanyInsider Ownership
Avid Technology, Inc. stock logo
AVID
Avid Technology
7.00%
Docebo Inc. stock logo
DCBO
Docebo
N/A
3D Systems Co. stock logo
DDD
3D Systems
3.45%
Enfusion, Inc. stock logo
ENFN
Enfusion
39.18%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Avid Technology, Inc. stock logo
AVID
Avid Technology
1,48544.04 million40.96 millionOptionable
Docebo Inc. stock logo
DCBO
Docebo
90030.38 millionN/ANot Optionable
3D Systems Co. stock logo
DDD
3D Systems
2,032133.43 million128.83 millionOptionable
Enfusion, Inc. stock logo
ENFN
Enfusion
1,102128.07 million77.89 millionOptionable

AVID, DDD, DCBO, and ENFN Headlines

SourceHeadline
Enfusion Announces Date of First Quarter 2024 ResultsEnfusion Announces Date of First Quarter 2024 Results
businesswire.com - April 18 at 8:30 AM
Enfusion Inc Class AEnfusion Inc Class A
morningstar.com - April 17 at 9:12 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
prnewswire.com - April 12 at 2:40 PM
Vanguard Group Inc. Purchases 512,479 Shares of Enfusion, Inc. (NYSE:ENFN)Vanguard Group Inc. Purchases 512,479 Shares of Enfusion, Inc. (NYSE:ENFN)
marketbeat.com - April 12 at 4:08 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
prnewswire.com - April 4 at 7:15 PM
The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
msn.com - April 4 at 7:13 AM
Will Enfusion (ENFN) Grow Revenue And Expand Margins In The Future?Will Enfusion (ENFN) Grow Revenue And Expand Margins In The Future?
finance.yahoo.com - April 2 at 10:49 AM
ConnexPay Appoints Ben Peters as Chief Executive OfficerConnexPay Appoints Ben Peters as Chief Executive Officer
businesswire.com - April 2 at 7:30 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
prnewswire.com - March 27 at 5:25 PM
Enfusion’s Growth Strategy Met with Sell Rating Amid Market and Strategic ChallengesEnfusion’s Growth Strategy Met with Sell Rating Amid Market and Strategic Challenges
markets.businessinsider.com - March 22 at 1:49 AM
Analysts’ Opinions Are Mixed on These Technology Stocks: GoDaddy (GDDY) and Enfusion (ENFN)Analysts’ Opinions Are Mixed on These Technology Stocks: GoDaddy (GDDY) and Enfusion (ENFN)
markets.businessinsider.com - March 21 at 3:44 PM
Stifel Nicolaus Keeps Their Buy Rating on Enfusion (ENFN)Stifel Nicolaus Keeps Their Buy Rating on Enfusion (ENFN)
markets.businessinsider.com - March 20 at 7:43 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
prnewswire.com - March 19 at 5:20 PM
Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024
markets.businessinsider.com - March 15 at 7:51 AM
Enfusion, Inc. (ENFN) Q4 2023 Earnings Call TranscriptEnfusion, Inc. (ENFN) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 14 at 2:24 PM
Enfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Call TranscriptEnfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 14 at 9:23 AM
Analysts Offer Insights on Technology Companies: Copperleaf Tech (OtherCPLFF), Rackspace Technology (RXT) and Enfusion (ENFN)Analysts Offer Insights on Technology Companies: Copperleaf Tech (OtherCPLFF), Rackspace Technology (RXT) and Enfusion (ENFN)
markets.businessinsider.com - March 13 at 2:26 PM
William Blair Reaffirms Their Buy Rating on Enfusion (ENFN)William Blair Reaffirms Their Buy Rating on Enfusion (ENFN)
markets.businessinsider.com - March 12 at 10:52 PM
Enfusion reports mixed Q4 results; initiates FY24 outlookEnfusion reports mixed Q4 results; initiates FY24 outlook
msn.com - March 12 at 12:50 PM
Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesEnfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
zacks.com - March 12 at 11:00 AM
Enfusion, Inc. (ENFN) Lags Q4 Earnings EstimatesEnfusion, Inc. (ENFN) Lags Q4 Earnings Estimates
zacks.com - March 12 at 10:46 AM
Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 ResultsEnfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results
finance.yahoo.com - March 12 at 7:49 AM
Earnings Outlook For EnfusionEarnings Outlook For Enfusion
benzinga.com - March 11 at 4:22 PM
Major Purchase Alert: Oleg Movchan Invests $120K In Enfusion StockMajor Purchase Alert: Oleg Movchan Invests $120K In Enfusion Stock
benzinga.com - March 6 at 5:35 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Avid Technology logo

Avid Technology

NASDAQ:AVID
Avid Technology, Inc., together with its subsidiaries, develops, markets, sells, and supports software and integrated solutions for video and audio content creation, management, and distribution in the United States and internationally. The company's video products and solutions include the Media Composer, a cloud-enabled solution used to edit video content; Avid NEXIS shared storage systems; Maestro solutions for the integration of virtual sets, augmented reality, and video wall control into existing workflows; AirSpeed 5000 and AirSpeed 5500 on-air server solutions; and MediaCentral, a media production suite. Its audio products and solutions comprise Pro Tools digital audio software solutions to facilitate the audio production process; Sibelius solution to create, edit, and publish musical scores; S1 and dock line audio control surface; S4 and S6 audio control surfaces; and VENUE | S6L live sound system for mixing audio for live sound reinforcement. The company also provides Avid Link, a mobile application to connect with other artists, producers, mixers, composers, editors, videographers, movie makers, and graphic designers; FastServe video server that assists broadcasters in making the move to UHD and IP based workflows with a new and modular architecture; and hardware products, such as I/O devices, interfaces, and audio and video processing equipment. In addition, it offers various maintenance contracts and support services; professional services, such as workflow design and consulting, program and project management, system installation and commissioning, and custom development and role-based product level training; and public and private training to customers and alliance partners, as well as develops and licenses curriculum content for use by third party Avid Learning partners to deliver training to customers, users, and alliance partners. Avid Technology, Inc. was incorporated in 1987 and is headquartered in Burlington, Massachusetts.
Docebo logo

Docebo

NASDAQ:DCBO
Docebo Inc. operates as a learning management software company that provides artificial intelligence (AI)-powered learning platform in North America and internationally. It offers Learning Management System (LMS) to train internal and external workforces, partners, and customers. The company's cloud platform consists of a learning suite, which includes Docebo Learn LMS, a cloud-based learning platform that allows learning administrators to deliver personalized learning; Docebo Shape, an AI-based learning content creation tool, which enables learning administrators to turn internal and external resources into engaging, multilingual, and microlearning content to share across the business; Docebo Content that allows off-the-shelf learning content by partnering content specialist; Docebo Learning Impact, a learning measurement tool that enables administrators to prove and improve training programs; Docebo Learn Data, which gives a comprehensive view on learning data to business results; Docebo Connect that connects Docebo to custom tech stack and making integrations; and Docebo Flow that allows businesses to directly inject learning into the flow of work. It also offers Docebo for Salesforce, a native integration that leverages Salesforce's application programming interface and technology architecture to produce a learning experience; Docebo Embed that allows original equipment manufacturers to embed and re-sell Docebo as a part of their software; Docebo Mobile App Publisher product that allows companies to create and publish own branded version of Docebo Go.Learn mobile learning applications; Docebo Extended Enterprise which breeds customer education, partner enablement, and retention; Docebo Discover, Coach & Share that enhances the learning experience to create a culture of social learning; and Docebo for Microsoft Teams, that brings learning directly into Microsoft Teams. The company was founded in 2005 and is headquartered in Toronto, Canada.
3D Systems logo

3D Systems

NYSE:DDD
3D Systems Corporation provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers 3D printers technologies, such as stereolithography, selective laser sintering, direct metal printing, multi jet printing, color jet printing, polymer extrusion, and extrusion and SLA based bioprinting that transform digital data input generated by 3D design software, computer aided design (CAD) software, or other 3D design tools into printed parts. It also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and biocompatible materials. In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as solutions for product design, simulation, mold and die design, 3D scan-to-print, reverse engineering, production machining, metrology, and inspection and manufacturing workflows under the Geomagic brand. Further, it offers 3D Sprint and 3DXpert, a proprietary software to prepare and optimize CAD data and manage the additive manufacturing processes, which provides automated support building and placement, build platform management, print simulation, and print queue management; and Bioprint Pro, a software solution that allows researchers to design and bioprint repeatable experiments. Additionally, the company provides maintenance and training services; manufacturing services; and software and precision healthcare services. It primarily serves companies and small and midsize businesses in medical, dental, automotive, aerospace, durable goods, government, defense, technology, jewelry, electronic, education, consumer goods, energy, biotechnology, and other industries through direct sales force, channel partners, and appointed distributors. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.
Enfusion logo

Enfusion

NYSE:ENFN
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.